Get the Stockscreener App
0.5964
2.07%
-0.0126
Pre-market:
.57
-0.0264
-4.43%
Metavia Inc stock is traded at $0.5964, with a volume of 2.28M.
It is down -2.07% in the last 24 hours and down -7.95% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$0.609
Open:
$0.6435
24h Volume:
2.28M
Relative Volume:
8.30
Market Cap:
$11.68M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.11%
1M Performance:
-7.95%
6M Performance:
-65.72%
1Y Performance:
+0.00%
1-Day Range:
$0.5555
$0.6612
1-Week Range:
$0.5555
$0.6634
52-Week Range:
$0.5555
$2.75
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
0.5964 | 11.93M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.54 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
419.56 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
690.32 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
304.30 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
Visual trend scoring systems applied to MetaVia Inc.Free Alert Feed for Momentum Based Picks - Newser
Top chart patterns to watch in MetaVia Inc.Low Volatility Stock Analysis With Confidence - Newser
MetaVia Partners with Syntekabio for DA-1241 Research - TipRanks
MetaVia Announces AI-Driven Collaboration with Syntekabio to Explore Additional Indications for DA-1241 - PR Newswire
Applying big data sentiment scoring on MetaVia Inc.Investment Timeline and ROI Summary Report - Newser
Intraday pattern recognizer results for MetaVia Inc.Trend Following Ideas with Volume Confirmation - Newser
Understanding MetaVia Inc.’s price movementMinimal Risk Growth Investment Opportunity Analysis - Newser
What institutional flow reveals about MetaVia Inc.Free Trend Analysis for Safer Trades - Newser
Is it the right time to buy MetaVia Inc. stockBuild wealth faster with consistent investment plans - Jammu Links News
Is now a turning point for MetaVia Inc.High Probability Trade Outcome Prediction - Newser
Why MetaVia Inc. stock attracts strong analyst attentionFree Community Verified Stock Suggestions - Newser
What institutional investors are buying MetaVia Inc. stockAccelerate your capital gains today - Jammu Links News
What is MetaVia Inc. company’s growth strategyGet real-time alerts on high-potential stocks - Jammu Links News
What are analysts’ price targets for MetaVia Inc. in the next 12 monthsCapitalize on market trends before they peak - Jammu Links News
Should I hold or sell MetaVia Inc. stock in 2025Get daily updates on market movers and shakers - Jammu Links News
How does MetaVia Inc. compare to its industry peersGet professional guidance for market timing - Jammu Links News
Is MetaVia Inc. stock overvalued or undervaluedNavigate market shifts with confidence - Jammu Links News
What are the latest earnings results for MetaVia Inc.Build your wealth with consistent stock growth - Jammu Links News
Why is MetaVia Inc. stock attracting strong analyst attentionCapitalize on momentum-driven stocks - Jammu Links News
Detecting support and resistance levels for MetaVia Inc.Technical Insight Guide for Safer Trades - newser.com
Is MetaVia Inc. stock entering bullish territoryEntry Opportunity Screener with Confirmation - Newser
Historical volatility pattern of MetaVia Inc. visualizedFree Real-Time Market Sentiment Tracking Tool - Newser
What are the technical indicators suggesting about MetaVia Inc.Advanced Screener Entry Points For Consistent Profits - Jammu Links News
How to monitor MetaVia Inc. with trend dashboardsGrowth Watchlist for Long Term Positioning - Newser
What makes MetaVia Inc. stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
How MetaVia Inc. stock performs during market volatilityReal-Time Setup Summary with ROI Focus - Newser
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):